Elevated CA15-3 or CEA or CA27-29
1 clinical trials · Condition
◉ Watch Elevated CA15-3 or CEA or CA27-29
| Record | Firm | Date |
|---|---|---|
| S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer (NCT03723928) | SWOG Cancer Research Network | 2018-09-17 |
Track Elevated CA15-3 or CEA or CA27-29 automatically
Every clearance here is in the API, with alerts when new ones post.